Khloris Biosciences, Inc.
San Jose, USA
|
Description:
Khloris is the first and only company to develop an iPSC-derived whole cell vaccine for the treatment of cancer. The company is also developing iPSC-derived cardiomyocytes as a novel cell therapy treatment for patients with cardiovascular diseases.
Khloris is the first and only company to develop an iPSC-derived whole cell vaccine for the treatment of cancer. The company is also developing iPSC-derived cardiomyocytes as a novel cell therapy treatment for patients with cardiovascular diseases.